While seated at home at approximately 2030 on (b)(6) 2020, the patient began experiencing spontaneous convulsions, primarily affecting the left body.Per patient's husband, the seizure lasted greater than 30 seconds but less than 5 minutes.The patient returned to normal level of consciousness, but reported no recall of the event.The patient was immediately transported to the emergency department for evaluation of possible seizure.The patient's head ct demonstrated no acute changes and showed all dbs leads in place.Her neurological exam appeared normal except for left sided weakness at 90% baseline.The patient was restarted on keppra 750mg twice a day and scheduled for follow-up with her neurologist.Although the patient was not receiving any brain stimulation nor was she undergoing any study-related interventions leading up to or during the event, a causal connection to the study cannot be ruled out.Fda safety report id# (b)(4).
|